Euroland - Kyowa Kirin Co., Ltd. - Latest press releases / Share Data / Share Price / Chart / Graph / Technical Analysis / Financial Information / Year In Brief / Strategy / Goals / Balance Sheet / Income Statement / Cash Flow / Annual Reports / Interim Reports / Press Releases / Dividends

TimeZone

Currency

Language

HOME

ABOUT US MY EUROLAND USERS’ PAGE CORPORATE SITES CONTACT US SITE OVERVIEW LINKS


Back

Corporate Information
	Company Presentation
	Business Segments
	Strategy & Goals
	President’s Message
	Year in Brief
	Management
	Subsidiaries
	Acquisitions & Divestments
	Addresses
News & Reports
	Reports
	Presentations
	Press releases
Financial Information
	Financial Summary
	Income Statement
	Balance Sheet
	Cash Flow
	Illustrations
Shareholder Information
	Shareholders
	Shares & Dividends
	Annual General Meeting
	Financial Calendar

Share Tools
	Share Graph
	Java Share Graph
	Investment calculator
	Share price look-up

http://www.kyowa-kirin.com

Kyowa Kirin Co., Ltd.
1-9-2, Otemachi, Chiyoda-ku
100-0004 Tokyo
JAPAN
Tel: ‎81-3-5205-7200
Fax: ‎81-3-5205-7129

Print this page

Send to a Friend E-mail this page to your friend

Disclaimer

Latest press releases

(2015-12-18 12:39:49)	Launch of the Web Comic "The Story of Basic Immunology"
(2015-12-08 07:51:34)	Kyowa Medex Launched "Liaison 25 -hydroxyvitamin D Total" in Japan
(2015-12-03 07:50:58)	Kyowa Hakko Kirin Announces Initiation of Global Phase 3 Study of KRN23 in Adults with X-Linked Hypophosphatemia (XLH) (70KB)
(2015-12-02 07:49:36)	Kyowa Hakko Kirin Announces Positive Interim 40-Week Data from Pediatric Phase 2 Study of KRN23 in X-Linked Hypophosphatemia (41KB)
(2015-12-01 07:48:25)	Kyowa Hakko Kirin Announces Commencement of Phase 3 Clinical Study of KHK7580 in Patients with Secondary Hyperparathyroidism in Japan
(2015-10-28 08:30:04)	Consolidated Financial Summary Fiscal 2015 Third Quarter (110KB)
(2015-10-28 08:29:21)	Appendix to the Consolidated Financial Summary Fiscal 2015 Third Quarter (255KB)
(2015-10-28 08:26:24)	Notice Concerning Change of the Number of Shares to Constitute One Unit Share and Partial Amendment to the Articles of Incorporation (89KB)
(2015-07-31 09:56:47)	Consolidated Financial Summary Fiscal 2015 Interim (113KB)
(2015-07-31 09:55:03)	Appendix to the Consolidated Financial Summary Fiscal 2015 (249KB)
(2015-07-31 09:54:00)	Results Presentation Fiscal 2015 Interim (1,036KB)
(2015-07-30 09:53:14)	Kyowa Hakko Kirin Submits Application for Approval in Japan for Brodalumab (KHK4827)
(2015-07-30 09:52:06)	Kyowa Hakko Kirin and Bristol-Myers Squibb Announce Immuno-Oncology Clinical Collaboration Studying Mogamulizumab and Opdivo (nivolumab) in Advanced Solid Tumors in the U.S. (96KB)
(2015-07-28 09:00:10)	Kyowa Hakko Kirin initiated a Pivotal Phase 3 Trial of Benralizumab (KHK4563) for COPD in Japan
(2015-07-27 10:32:22)	Launch of Reconfigured Kyowa Hakko Kirin Global Website
(2015-07-24 10:31:14)	Kyowa Hakko Kirin Revises Forecasts (39KB)
(2015-07-24 10:30:27)	Fujifilm Kyowa Kirin Biologics establishes joint venture with AstraZeneca to develop and commercialise anti-VEGF biosimilar (85KB)
(2015-07-23 10:28:55)	Kyowa Hakko Kirin Announces Results of the Phase 3 Studies of KHK4827 in Subjects with Psoriasis in Japan
(2015-07-16 12:32:12)	Kyowa Hakko Kirin Enters Option Agreement with AstraZeneca for Commercialisation of Benralizumab (KHK4563) in JapanPDF file:New window opens(58KB)
(2015-07-03 12:27:51)	Approval for ACOALAN® in Japan
(2015-06-26 10:50:34)	Cantargia licenses BioWa POTELLIGENT® Technology platform for production of lead product candidate (492KB)
(2015-06-16 12:40:28)	Launch of REGPARA® Tablets 12.5mg in Japan
(2015-04-28)	Consolidated Financial Summary Fiscal 2015 First Quarter (108KB)
(2015-04-28)	Appendix to the Consolidated Financial Summary Fiscal 2015 First Quarter (204KB)
(2015-04-09 12:36:16)	Completion of Construction for Amino Acid Manufacturing Plant in Thailand
(2015-04-01 06:12:02)	Entries Now Publicly Available from the "Commitment to Life" Contest Movie! Movies show the philosophy of employees across the Kyowa Hakko Kirin Group
(2015-03-31 09:35:20)	Completion of Construction for New Research Building in Fuji Research Park
(2015-03-31 09:34:51)	Matters concerning controlling shareholders (41KB)
(2015-03-20 09:34:02)	Notice regarding allotment of stock acquisition rights(stock compensation-type stock options) (43KB)
(2015-03-16 05:40:43)	Change in the Company Name (trade name) at DAIICHI FINE CHEMICAL CO., LTD.
(2015-03-05 05:24:25)	Kyowa Hakko Kirin Announces Commencement of Phase 2 Clinical Study of RTA 402 in CKD patients with type 2 diabetes in Japan
(2015-02-17)	Position and policies concerning the reduction of the minimum investment unit (24KB)
(2015-02-17)	Notice regarding stock acquisition rights for the purpose of granting stock compensation-type stock options (19KB)
(2015-02-17)	Transfer of BioWa's "External Innovation Engine" In-Licensing Activities to Kyowa Hakko Kirin California
(2015-02-16 05:55:35)	Approval of REGPARA® Tablets 12.5mg in Japan (28KB)
(2015-01-30 08:16:55)	Consolidated Financial Summary Fiscal 2014 (318KB)
(2015-01-30 08:16:03)	Appendix to the Consolidated Financial Summary Fiscal 2014 (226KB)
(2015-01-30 08:15:01)	Results Presentation Fiscal 2014 (1,621KB)
(2015-01-30 08:14:25)	Change of Representative Directors at Kyowa Hakko Bio (31KB)
(2015-01-08 05:36:56)	Kyowa Hakko Kirin and Syndax Announce an Exclusive License Agreement to Develop and Commercialize Entinostat in Japan and Korea(52KB)

2015

Corporate Information

News & Reports

Financial Information

Shareholder Information

Share Tools